Диссертация (1154843), страница 29
Текст из файла (страница 29)
Growth and development in children recovering from bronchopulmonarydysplasia / T. Markestad, P.M. Fitzhardinge // J. Pediatrics. -1981. –V.98. –P.597–602.278. May С. Lung function abnormalities infants developing bronchopulmonary dysplasia / С.May, C. Kennedy, A.D. Milner , et al. // Arch Dis Child. -2011. –V.96. –P.1014–9.279. Mayes L. Severe bronchopulmonary dysplasia: a retrospective review / L.
Mayes, E. Perkett,M.T. Stahleman //Acta Paediatrica. -1983. –V.72 (1–2). –P. 220–229.280. McConnochie K. M. Wheezing at 8 and 13 years: changing importance of bronchiolitis andpassive smoking / K.M. McConnochie, K.J. Roghmann // Pediatr. Pulmonol. — 1989. –V. 6. –P.138–146.281. McLeod A. Respiratory health in a total very low birthweight / A.
McLeod, P. Ross, S.Mitchell et.al. // Arch Dis Child. -1996. –V.74. –P.188-194.282. Mok J. Y. Q. Outcome of lower respiratory tract infection in infants: preliminary report of aseven year follow-up study / J. Y. Q.Mok, H.Simpson // BMJ. — 1982. –V. 285. –P.333–337.283. Narang I, Rosenthal M, Cremonesini D et.al. Longitudinal evaluation of airway function 21years after preterm birth / I. Narang, M. Rosenthal, D. Cremonesini et.al. // Am J Respir Crit CareMed. -2008. –V.178. – P.74–80.284.
Nathalie L. Respiratory consequences of prematurity: evolution of a diagnosis and developmentof a comprehensive approach / L.Nathalie, A. Ballard, H. Ellenberg, D. Davis, et al.// J Perinatol. 2015, May. –V.35(5). –P.313–321.285. Ng G.Y.T., da Silva O., Ohlsson A. Bronchodilation for the prevention and treatment of chroniclung disease in preterm infants. Cochrane Database Syst.
Rev. 2001;23:CD003214.286.Nixon P.A. Follow-up study of a randomized controlled trial of postnataldexamethasone therapy in very low birth weight infants: effects on pulmonary outcomes at 8–11years of age / P.A. Nixon, L.K. Washburn, M.S. Schechter, T/M.O’Shea // J Pediatr. -2007. –V.150(4). –P.345–350.287. Northway W.H. Late pulmonary sequlae of bronchopulmonary dysplasia / W.H. Northway,R.B. Moss, K.B. Carlisle, et al. // N.
Engl. J. Med. - 1990. - Vol. 323. - P. 1793-1799.288. Northway WH Jr. Pulmonary disease following respirator therapy of hyaline-membranedisease. Bronchopulmonary dysplasia / WH Jr. Northway, R.C. Rosan, D.Y. Porter // N Engl J Med.-1967. –V.276(7). –P.357–368.289.Oh W. Association between fluid and weight loss during the first ten days oflife and risk of bronchopulmonary dysplasia in extremely low birth weight infants / W.
Oh,B.B.Poindexter, R.Peritt // J Pediat 2005. –V.147. –P.786–790.290.Ohlsson A . Intravenous immunoglobulin for preventing infection in pretermand/or low birth weight infants / A. Ohlsson, J.B. Lacy. // Cochrane Database Syst Rev. -2013,Jul. №2;7 :CD000361. doi: 10.1002/14651858.CD000361.pub3.139291.Olsen I.E. Intersite differences in weight growth velocity of extremelypremature infants / I.E.
Olsen, D.K. Richardson, C.H. Schmid et al. // Pediatrics. -2002. –V.110. –P.1125–1131.292. Onland W. Finding the Optimal Postnatal Dexamethasone Regimen for Preterm Infants at Riskof Bronchopulmonary Dysplasia: A Systematic Review of Placebo-Controlled Trials / W. Onland, M.Offringa, A.P. De Jaegere, A.H. van Kaam // Pediatrics. -2009.
–V.123(1). –P.367–77.293. O'Reilly M. Altered small airways in aged mice following neonatal exposure to hyperoxic gas /M. O'Reilly, R. Harding, F. Sozo // Neonatology. -2014. –V.105(1). –P.39–45.294. O'Reilly M.A. Neonatal hyperoxia enhances the inflammatory response in adult mice infectedwith influenza A virus / M.A. O'Reilly, S.H. Marr, M. Yee,et al. // Am J Respir Crit Care Med. 2008. –V.177(10).
–P.1103–1110.295. Parker R.A. Improved surviral acconnts for most, but not all, of increase in bronchopulmonarydysplasia / R.A. Parker, D.P. Lindstrom, R.B. Cotton // Pediatrics. -1992. –V.90(8). –P.663.296. Patel R.M., Kandefer S, Walsh MC, et al. Causes and timing of death in extremely prematureinfants from 2000 through 2011 / R.M. Patel , S. Kandefer, M.C. Walsh , et al. // N Engl J Med. 2015. –V.372. –P.331.297. Payne N.R.
Reduction of bronchopulmonary dysplasia after participating in a groupbreathsavers Vermont Oxford Network Neonatal intensive collaboration to improve the quality ofcare / N.R. Payne, M .LaCorte, P. Karna // J Pediatrics. -2006. –V.118. –P.73-77.298. Perotta C. Chest physiotherapy for acute bronchiolitis in paediatric patients between 0 and 24months old / C. Perotta, Z. Ortiz, M. Roque // Cochrane Database Syst Rev. – 2005.
– Vol. 2 –299. Peter T.K. Chan MD, Marc Goldstein MD, Zev Rosenwaks MD. Reproductive MedicineSecrets. Hanley & Belfus, INC, 2004; 269–352 p. Russian (Чен П. Т. К., Гоулдстайн М.,Роузенвэкс З. Секреты репродуктивной медицины. Пер. с англ. под общ. ред. акад.РАМН, проф. В. И. Кулакова. -М.: МЕДпресс-информ, 2006. -269–352 с.300. Pierce M. R. The role of inflammation in the pathogenesis of bronchopulmonary dysplasia /M. R. Pierce, E. Bancalary // Pediatr. Pulmonol.
— 1995. — V. 19. — P. 371–388.301. Pierro M. Short-term, long-term and paracrine effect of human umbilical cord-derived stemcells in lung injury prevention and repair in experimental bronchopulmonary dysplasia / M. Pierro, L.Ionescu, T.
Montemurro, et al. // Thorax. -2012. – V.1. –P.76.302. Pierro M. Mesenchymal stem cells for the prevention and treatment of bronchopulmonarydysplasia in preterm infants (Protocol) / Pierro M, Thébaud B, Soll R // The Cochrane Library 2015,Issue 11.303. Postnatal Corticosteroids to Treat or Prevent Chronic Lung Disease in Preterm Infants /American Academy of pediatrics // Pediatrics. – 2002. -№109 (2). – Р. 330–338.304.Powers G.C. Postdischarge growth and development in a predominantlyHispanic, very low birth weight population / G.C. Powers, R.Ramamurthy et al.
// Pediatrics. 2008. –V.122. –P.1258–1265.305. Prost, M.E. Problems of the pathogenesis of retinopathy of prematurity / M.E. Prost //Progress in Retinopathy of Prematurity. – 2009. – P. 65-69.306. Pullan C. R. Wheezing, asthma and pulmonary dysfunction 10 years after infection withrespiratory syncytial virus in infancy / C. R.
Pullan, E. N. Hey // BMJ. — 1982. –V. 284. –P.1665–1669.307. Ratner V. Mechanical Ventilation Causes Pulmonary Mitochondrial Dysfunction and DelayedAlveolarization in Neonatal Mice / V. Ratner, S.A. Sosunov, Z.V. Niatsetskaya, et al. // Am J RespirCell Mol Biol. -2013, Aug, -P.27.308.Rennie J. M. A Manual of Neonatal Intensive Care / J. M. Rennie, N. R.Roberton // - Oxford University Press, 2002. -Chronic lung disease. — P. 204–214.309. Rhein L.M. Effects of caffeine on intermittent hypoxia in infants born prematurely: arandomized clinical trial / L.M.
Rhein, N.R. Dobson, R.A. Darnall, et al. // JAMA Pediatr. -2014. –V. 168(3). –P.250–257.140310. Robin B. Pulmonary function in bronchopulmonary dysplasia / B. Robin, Y.J. Kim, J. Huth,et al. // Pediatr Pulmonol. -2004. –V.37(3). –P.236–242.311. Rogalski M. Prophylaxe and Therapie des neonatalen Atemnotsyndroms durch endotrachealeApplikationexogenen Surfactants-eineLiteraturubersicht / M. Rogalski, A. Schwerecke, et al. //Z.Klin. Mrd. -1991. –V.46.
–P. 985-992.312. Rojas-Reyes M.X., Morley C.J., Soll R. Prophylactic versus selective use of surfactant inpreventing morbidity and mortality in preterm infants. Cochrane Database Syst. Rev.2012:CD000510.313. Ryan R.M. A new look at bronchopulmonary dysplasia classification / R.M. Ryan // J Perinatol.-2006. –V.26(4). –P. 207–209.314.
Sahni R. Is the new definition of bronchopulmonary dysplasia more useful? / R. Sahni, A.Amari, M. Suri, et al. // J. Perinatol. -2005. –V.25. –P.41315. Sandri F. CURPAP Study Group: Prophylactic or early selective surfactant combined withnCPAP in very preterm infants / F. Sandri, R. Plavka, G. Ancora, et al. // Pediatrics. -2010. –V.125. –P.402–409.316. Sazonova A. Obstetric outcome in singletons after in vitro fertilization withcryopreserved/thawed embryos / A. Sazonova, K.
Källén, A. Thurin-Kjellberg et al. // HumReprod. -2012. –V.27. –P.1343—1350.317. Schelonka R. Critical appraisal of the role of Ureaplasma in the development ofbronchopulmonary dysplasia with metaanalytic techniques / R. Schelonka, B. Katz, K.Whites, et al.// Pediatr Infect Dis/ -2005. –V.24. –P.1033–1039.318. Schmidt B. Caffeine for Apnea of Prematurity Trial Group: Caffeine therapy for apnea ofprematurity / B.
Schmidt, R.S.Roberts, P. Davis, et al. // N. Engl. J. Med. -2006. –V.354. –P.2112–21.319. Schneibel K.R. Inflammatory mediator patterns in tracheal aspirate and their association withbronchopulmonary dysplasia in very low birth weight neonates / K.R. Schneibel, A.M. Fitzpatrick,X.D. Ping, et al. // J Perinatol. – 2013. –V.33(5). –P.383–387.320. Schroeder S.
A. Cellular interstitial pneumonitis in infants. A clinicopathologic study / S. A.Schroeder, D. C.Shanon, E. J. Mark // Chest. — 1992. — V. 101, № 4. — P. 1065–1069.321. Seiberth V. Risk factors in retinopathy of prematurity. A multivariate statistical analysis / V.Seiberth, O. Linderkamp // Ophthalmologica. – 2000. – Vol. 214, №2.
– Р. 131-135322. Senatorova A.S., Logvinova O.L., Chernenko L.N., Muratov G.R. Features ofbronchopulmonary dysplasia course in children at the present stage / A.S. Senatorova, O.L.Logvinova, L.N. Chernenko, G.R. Muratov // Клінічна педіатрія. -2011. –V.3(30) . –P.55-61.323. Shah P.S. The results of the Canadian Network for newborn preterm infants <29 weeks'gestation in a 10-year period in Canada: cause for concern? / P.S. Shah, K.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
